MY ACCOUNT | NEWSLETTER |

Genetic test marketed for pure breeds


Embark Veterinary, Inc., a company focused on genetics in dogs, has marketed its DNA Test for Purebred Dogs, which the company states is the first of its kind. The test can alert owners to potential health issues or breed characteristics. The test costs $199, with rebates possible at the company website. 

"Until now, there has not been a dog DNA product on the market specifically designed for purebred dogs, but every dog owner deserves the most accurate and detailed data on their dog's health," said Ryan Boyko, co-founder and chief executive officer of Embark. "Not only will this test better inform owners, veterinarians, and breeders; but it will accelerate our health discovery engine and improve insights into breed-specific health conditions and traits, fueling discoveries that will help extend dogs' lives by three years within the decade."

The test, which was created by geneticists and veterinarians, can aid in identifying genetic predisposition to disease, allowing for food, care, or activity changes. The company’s DNA test also provides a metric on genetic diversity, which can offer a possible window on overall health and likely lifespan. 

"We see that highly genetically diverse dogs live on average 2-3 years longer than dogs with low genetic diversity and have fewer health problems over their lifetime," said Adam Boyko, co-founder and chief science officer at Embark. "While owners can't change their dog's genetics, they can be vigilant about their dog's care and exercise knowing their dog's unique health risks."


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Clinical findings and survival time in dogs with myxomatous mitral valve disease at the American College of Veterinary Internal Medicine stage D.

Like0
Dislike0

Evaluating the correlation between serum fructosamine concentration and interstitial glucose concentration in cats with diabetes mellitus.

Like0
Dislike0

Evaluated the immune efficacy of a bivalent inactivated vaccine against post-weaning multisystemic wasting syndrome and mycoplasmal pneumonia of swine.

Like0
Dislike0

Therapy dog Gracie takes on new mission in fight against blastomycosis

Like0
Dislike0

Veterinary Imaging Market by Product, Animal Type, Application, Modality, End User, Region - Global Forecast to 2031

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top